IDSA-FDA Community-Acquired Pneumonia Workshop Supplement We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at... http://cid.oxfordjournals.org/content/51/Supplement_1.toc - 105 KB Details | Not yet rated

	IDSA Comments on Drug Shortages Task Force and Strategic Plan (PDF) Thank you for the opportunity to respond to the Food and Drug Administration’s (FDA’s) request for comments on the Drug Shortages Task Force and Strategic Plan. I write on... http://www.idsociety.org/.../IDSA Comments on Drug Shortages Task Force and S... - 4 pages Details | Not yet rated

	Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the... We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. There is a critical need for new... http://cid.oxfordjournals.org/.../1031.full?sid=003a29cc-73ee-4cbe-aeb4-2d5c5... - 279 KB Details | Not yet rated

	CTTI Antibacterial Drug Development Workshop Summary August 20, 2012 Statistical Think Tank Slides There are currently no items in this folder. Document Actions Send this https://www.ctti-clinicaltrials.org/.../publications-and-presentations - 24 KB Details | Not yet rated

	IDSA Comments on FDA Draft Guidance on Developing Drugs for Complicated Intra-Abdominal Infections (cIAI) (PDF) IDSA represents nearly 10,000 infectious diseases physicians and scientists devoted to patient care, prevention, public health, education, and research in the area of... http://www.idsociety.org/.../IDSA Comments on FDA cIAI Guidance 122112.pdf - 5 pages Details | Not yet rated

	IDSA Comments on Developing a List of Qualifying Pathogens (PDF) The Infectious Diseases Society of America (IDSA) is pleased to submit comments for the above referenced Food and Drug Administration (FDA) public hearing on establishing a... http://www.idsociety.org/.../IDSA Comments on Qualifying Pathogen List 121812... - 5 pages Details | Not yet rated

	American Medical Association (AMA) Supports IDSA's Limited Population Antibiotic Drug (LPAD) Proposal (PDF) Whereas, Our American Medical Association (AMA) has longstanding policy supporting the development of new antibiotics and combatting antibiotic resistance through the... http://www.idsociety.org/.../Position_Papers/AMA HOD resolution LPAD(1).pdf - 4 pages Details | Not yet rated

	IDSA Comments on Upcoming HHS Antibiotic Incentives Study (PDF) 805 of the Food and Drug Administration Safety and Innovation Act (FDASIA). As you know, this provision calls upon the Department of Health and Human Services (HHS) to... http://www.idsociety.org/.../IDSA Comments on FDASIA Section 805 Implementat... - 5 pages Details | Not yet rated

	IDSA Comments on FDA Draft Guidance on Developing Drugs for Complicated Urinary Tract Infections (cUTI) (PDF) 10,000 infectious diseases physicians and scientists devoted to patient care, prevention, public health, education, and research in the area of infectious diseases. Our... http://www.idsociety.org/.../IDSA Comments on cUTI Draft Guidance 052412.pdf - 6 pages Details | Not yet rated

	IDSA Comments on FDA's Draft Guidance for Industry on Acute Bacterial Skin and Skin Structure Infections (ABSSSI) (PDF) IDSA represents more than 9300 infectious diseases physicians and scientists devoted to patient care, prevention, public health, education, and research in the area of... http://www.idsociety.org/.../IDSA Comments re FDA ABSSSI Guidance 111710.pdf - 20 pages Details | Not yet rated

Refine Your Results: